Neoadjuvant chemotherapy is an effective way of managing elderly women with advanced-stage ovarian cancer

被引：0
|
作者：
Glasgow, M. [1 ]
Yu, H. [1 ]
Rutherford, T. [1 ]
Azodi, M. [1 ]
Silasi, D. [1 ]
Santin, A. [1 ]
Schwartz, P. [1 ]
机构：
[1] Yale Univ, New Haven, CT USA
来源：
GYNECOLOGIC ONCOLOGY | 2010年 / 116卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
331
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [1] Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian cancer (FIGO Stage IIIC and IV)
    Glasgow, Michelle A.
    Yu, Herbert
    Rutherford, Thomas J.
    Azodi, Masoud
    Silasi, Dan-Arin
    Santin, Alessandro D.
    Schwartz, Peter E.
    JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (02) : 195 - 200
  • [2] Neoadjuvant chemotherapy in advanced-stage ovarian cancer - state of the art
    Margioula-Siarkou, Chrysoula
    Petousis, Stamatios
    Papanikolaou, Alexios
    Gullo, Giuseppe
    Margioula-Siarkou, Georgia
    Lagana, Antonio Simone
    Dinas, Konstantinos
    Guyon, Frederic
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2022, 21 (04): : 272 - 275
  • [3] Neoadjuvant chemotherapy before definite operative approach for women with advanced-stage epithelial ovarian cancer
    Wang, Peng-Hui
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2018, 57 (05): : 623 - 624
  • [4] Neoadjuvant chemotherapy for advanced-stage ovarian cancer: Are the ASCO and SGO recommendations warranted?
    Narod, Steven
    Sopik, Victoria
    GYNECOLOGIC ONCOLOGY, 2017, 144 (02) : 238 - 240
  • [5] Safety and efficacy of neoadjuvant chemotherapy with bevacizumab in advanced-stage peritoneal/ ovarian cancer patients
    Kusunoki, Soshi
    Terao, Yasuhisa
    Hirayama, Takashi
    Fujino, Kazunari
    Ujihira, Takafumi
    Ota, Tsuyoshi
    Takeda, Satoru
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2018, 57 (05): : 650 - 653
  • [6] Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer
    Sassen, Stefanie
    Schmalfeldt, Barbara
    Avril, Norbert
    Kuhn, Walther
    Busch, Raymonde
    Hoefler, Heinz
    Fend, Falko
    Naehrig, Joerg
    HUMAN PATHOLOGY, 2007, 38 (06) : 926 - 934
  • [7] Impact of neoadjuvant chemotherapy and postoperative adjuvant chemotherapy cycles on survival of patients with advanced-stage ovarian cancer
    Chung, Young Shin
    Kim, Yun-Ji
    Lee, Inha
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sunghoon
    Kim, Sang Wun
    Kim, Young Tae
    PLOS ONE, 2017, 12 (09):
  • [8] Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer
    Mazzeo, F
    Berlière, M
    Kerger, J
    Squifflet, J
    Duck, L
    D'Hondt, V
    Humblet, Y
    Donnez, J
    Machiels, JP
    GYNECOLOGIC ONCOLOGY, 2003, 90 (01) : 163 - 169
  • [9] Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center
    Mueller, Jennifer J.
    Zhou, Qin C.
    Iasonos, Alexia
    O'Cearbhaill, Roisin E.
    Alvi, Farah A.
    El Haraki, Amr
    Eriksson, Ane Gerda Zahl
    Gardner, Ginger J.
    Sonoda, Yukio
    Levine, Douglas A.
    Aghajanian, Carol
    Chi, Dennis S.
    Abu-Rustum, Nadeem R.
    Zivanovic, Oliver
    GYNECOLOGIC ONCOLOGY, 2016, 140 (03) : 436 - 442
  • [10] Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancer
    de Lange, N. M.
    Ezendam, N. P. M.
    Kwon, J. S.
    Vandenput, I
    Mirchandani, D.
    Amant, F.
    van der Putten, L. J. M.
    Pijnenborg, J. M. A.
    CURRENT ONCOLOGY, 2019, 26 (02) : E226 - E232
12345